These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38245963)

  • 1. Stimulant use and opioid-related harm in patients on long-term opioids for chronic pain.
    Appa A; McMahan VM; Long K; Shade SB; Coffin PO
    Drug Alcohol Depend; 2024 Mar; 256():111065. PubMed ID: 38245963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Provider reasons for discontinuing long-term opioid therapy following aberrant urine drug tests differ based on the type of substance identified.
    Wyse JJ; Morasco BJ; Dobscha SK; Demidenko MI; Meath THA; Lovejoy TI
    J Opioid Manag; 2018; 14(4):295-303. PubMed ID: 30234926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substance Use Disorder Treatment Following Clinician-Initiated Discontinuation of Long-Term Opioid Therapy Resulting from an Aberrant Urine Drug Test.
    Nugent SM; Dobscha SK; Morasco BJ; Demidenko MI; Meath THA; Frank JW; Lovejoy TI
    J Gen Intern Med; 2017 Oct; 32(10):1076-1082. PubMed ID: 28600754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do Urine Drug Tests Reveal Substance Misuse Among Patients Prescribed Opioids for Chronic Pain?
    Larochelle MR; Cruz R; Kosakowski S; Gourlay DL; Alford DP; Xuan Z; Krebs EE; Yan S; Lasser KE; Samet JH; Liebschutz JM
    J Gen Intern Med; 2022 Aug; 37(10):2365-2372. PubMed ID: 34405344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine Drug Testing Among Patients Prescribed Long-Term Opioid Therapy: Patient and Clinician Factors.
    Agnoli AL; Howe R; Magnan E; Jerant A; Colby D; Franks P
    J Am Board Fam Med; 2023 Aug; 36(4):537-541. PubMed ID: 37468213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinician Response to Aberrant Urine Drug Test Results of Patients Prescribed Opioid Therapy for Chronic Pain.
    Morasco BJ; Krebs EE; Adams MH; Hyde S; Zamudio J; Dobscha SK
    Clin J Pain; 2019 Jan; 35(1):1-6. PubMed ID: 30222612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rate of Fentanyl Positivity Among Urine Drug Test Results Positive for Cocaine or Methamphetamine.
    LaRue L; Twillman RK; Dawson E; Whitley P; Frasco MA; Huskey A; Guevara MG
    JAMA Netw Open; 2019 Apr; 2(4):e192851. PubMed ID: 31026029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Pain Intensity and Discontinuing Opioid Therapy or Transitioning to Intermittent Opioid Therapy After Initial Long-Term Opioid Therapy: A Retrospective Cohort Study.
    Hayes CJ; Krebs EE; Brown J; Li C; Hudson T; Martin BC
    J Pain; 2021 Dec; 22(12):1709-1721. PubMed ID: 34186177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risks of opioid overdose among New York State Medicaid recipients with chronic pain before and during the COVID-19 pandemic.
    Mannes ZL; Wheeler-Martin K; Terlizzi K; Hasin DS; Perry A; Pamplin JR; Crystal S; Cerdá M; Martins SS
    Prev Med; 2023 Dec; 177():107789. PubMed ID: 38016582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial disparities in discontinuation of long-term opioid therapy following illicit drug use among black and white patients.
    Gaither JR; Gordon K; Crystal S; Edelman EJ; Kerns RD; Justice AC; Fiellin DA; Becker WC
    Drug Alcohol Depend; 2018 Nov; 192():371-376. PubMed ID: 30122319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brief Report: The Association of Chronic Pain and Long-Term Opioid Therapy With HIV Treatment Outcomes.
    Merlin JS; Long D; Becker WC; Cachay ER; Christopoulos KA; Claborn K; Crane HM; Edelman EJ; Harding R; Kertesz SG; Liebschutz JM; Mathews WC; Mugavero MJ; Napravnik S; C OʼCleirigh C; Saag MS; Starrels JL; Gross R
    J Acquir Immune Defic Syndr; 2018 Sep; 79(1):77-82. PubMed ID: 29771793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of urine drug testing for patients with chronic pain: Results from a national cohort of U.S. veterans.
    Morasco BJ; Peters D; Krebs EE; Kovas AE; Hart K; Dobscha SK
    Subst Abus; 2016; 37(1):82-7. PubMed ID: 26516794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hazardous alcohol use is associated with greater pain interference and prescription opioid misuse among persons living with HIV and chronic pain.
    Ngo B; Liebschutz JM; Cheng DM; Colasanti JA; Merlin JS; Armstrong WS; Forman LS; Lira MC; Samet JH; Del Rio C; Tsui JI
    BMC Public Health; 2021 Mar; 21(1):564. PubMed ID: 33752634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term opioid therapy of non-cancer pain : Prevalence and predictors of hospitalization in the event of possible misuse.
    Häuser W; Schubert T; Scherbaum N; Tölle T
    Schmerz; 2020 May; 34(Suppl 1):8-15. PubMed ID: 30327867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discontinuation and tapering of prescribed opioids and risk of overdose among people on long-term opioid therapy for pain with and without opioid use disorder in British Columbia, Canada: A retrospective cohort study.
    Kennedy MC; Crabtree A; Nolan S; Mok WY; Cui Z; Chong M; Slaunwhite A; Ti L
    PLoS Med; 2022 Dec; 19(12):e1004123. PubMed ID: 36454732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment changes following aberrant urine drug test results for patients prescribed chronic opioid therapy.
    Morasco BJ; Krebs EE; Cavanagh R; Hyde S; Crain A; Dobscha SK
    J Opioid Manag; 2015; 11(1):45-51. PubMed ID: 25750164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term opioid therapy of non-cancer pain : Prevalence and predictors of hospitalization in the event of possible misuse].
    Häuser W; Schubert T; Scherbaum N; Tölle T
    Schmerz; 2018 Dec; 32(6):419-426. PubMed ID: 30242530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of the Pain Medication Questionnaire to predict aberrant urine drug tests: Results from a longitudinal cohort study.
    Morasco BJ; Iacocca MO; Lovejoy TI; Dobscha SK; Deyo RA; Cavese JA; Hyde S; Yarborough BJH
    Psychol Serv; 2021 Aug; 18(3):319-327. PubMed ID: 32673038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescription stimulant use during long-term opioid therapy and risk for opioid use disorder.
    Scherrer JF; Salas J; Grucza R; Wilens T; Quinn PD; Sullivan MD; Rossom RC; Wright E; Piper B; Sanchez K; Lapham G
    Drug Alcohol Depend Rep; 2022 Dec; 5():100122. PubMed ID: 36844161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A national population-based study of cannabis use and correlates among U.S. veterans prescribed opioids in primary care.
    Zaman T; Bravata DM; Byers AL; Krebs EE; Leonard SJ; Sandbrink F; Barker W; Keyhani S
    BMC Psychiatry; 2023 Mar; 23(1):177. PubMed ID: 36927526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.